Ourania Tatsis - Feb 14, 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Chief Reg. & Quality Off.
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 14, 2023
Transactions value $
-$95,527
Form type
4
Date filed
2/16/2023, 03:18 PM
Previous filing
Feb 14, 2023
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale -$21K -71 -0.11% $295.89 65.7K Feb 14, 2023 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$5.93K -20 -0.03% $296.48 65.7K Feb 14, 2023 Direct F1
transaction VRTX Common Stock Sale -$12.8K -43 -0.07% $297.98 65.6K Feb 14, 2023 Direct F1, F2, F4
transaction VRTX Common Stock Sale -$40.4K -135 -0.21% $299.60 65.5K Feb 14, 2023 Direct F1, F2, F5
transaction VRTX Common Stock Sale -$15.3K -51 -0.08% $300.58 65.4K Feb 14, 2023 Direct F1, F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1.
F2 Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $295.89 (range $295.36 to $296.32).
F4 Open market sales reported on this line occurred at a weighted average price of $297.98 (range $297.50 to $298.48).
F5 Open market sales reported on this line occurred at a weighted average price of $299.60 (range $299.19 to $300.16).
F6 Open market sales reported on this line occurred at a weighted average price of $300.58 (range $300.34 to $301.01).